Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
0.100 Biomarker disease BEFREE RP5063, a multimodal dopamine (DA) and serotonin (5-HT) modulator with high affinity for DA<sub>2/3/4</sub> and 5-HT<sub>2A/2B/7</sub> receptors and moderate affinity for SERT, is a novel therapeutic of special interest in the treatment of pulmonary arterial hypertension (PAH). 28576407 2017
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
0.100 Biomarker disease BEFREE Pulmonary arterial hypertension (PAH) has demonstrated multi-serotonin receptor dependent pathologies, characterized by increased tone (5-HT<sub>1B</sub> receptor) and complex lesions (SERT, 5-HT<sub>1B</sub>, 5-HT<sub>2B</sub> receptors) of the pulmonary vasculature together with right ventricular hypertrophy, ischemia and fibrosis (5-HT<sub>2B</sub> receptor). 28529483 2017
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
0.100 GeneticVariation disease BEFREE Association between serotonin transporter (SERT) gene polymorphism and idiopathic pulmonary arterial hypertension: a meta-analysis and review of the literature. 24075737 2013
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
0.100 GeneticVariation disease BEFREE The distribution of SERT gene alleles does not appear to be different in patients with PAH than in the normal population. 22177971 2012
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
0.100 AlteredExpression disease BEFREE We postulated that: 1) Tph1(-/-) mice express lower levels of pulmonary 5-HT transporter (SERT) when compared to wild-type controls, and 2) Tph1(-/-) mice display adaptive changes in the expression of non-serotonergic pulmonary genes which are implicated in PAH. 21464983 2011
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
0.100 Biomarker disease BEFREE A long (L)/short (S) (44 base pair insertion) functional polymorphism within the promoter of the transporter SLC6A4 gene has been reported to be associated with familial and idiopathic PAH. 20395645 2010
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
0.100 GeneticVariation disease BEFREE These findings suggest that 5-HTT polymorphisms may play a role in the etiology of VSD-related possible PAH. 19886858 2009
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
0.100 AlteredExpression disease BEFREE One intrinsic abnormality of pulmonary artery smooth muscle cells (PA-SMCs) in human idiopathic pulmonary hypertension (iPH) is an exaggerated proliferative response to internalized serotonin (5-HT) caused by increased expression of the 5-HT transporter (5-HTT). 16614302 2006
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
0.100 GeneticVariation disease BEFREE We found that homozygosity for the long variant of 5HTT was highly associated with idiopathic pulmonary hypertension in children, suggesting perhaps a more important role for 5HTT gene function in the pathogenesis of early onset disease. 16009349 2005
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
0.100 Biomarker disease BEFREE Among these, the finding of an association between PPH and the L-allelic variant of the serotonin transporter (5-HTT) gene indicates that 5-HTT, which controls smooth muscle hyperplasia, probably contributes to susceptibility to PPH or is an important modifier of the PPH phenotype. 12503718 2002
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
0.100 AlteredExpression disease BEFREE We conclude that 5-HTT activity plays a key role in the pathogenesis of PA-SMC proliferation in PPH and that a 5HTT polymorphism confers susceptibility to PPH. 11602621 2001